Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
You may also like
Prostaglandin E2 Induces MIR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression
- November 15, 2019
Prostaglandin E2 (PGE2) promotesRead more
Does Treating Hemochromatosis in Patients with Advanced Liver Fibrosis Improve Fibrosis?
- November 14, 2019
About 40% of patients with HFERead more